Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Sphingolipids and the unfolded protein response.

Bennett MK, Wallington-Beddoe CT, Pitson SM.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun 5. pii: S1388-1981(19)30094-0. doi: 10.1016/j.bbalip.2019.06.002. [Epub ahead of print] Review.

PMID:
31176037
2.

Autosomal-dominant biventricular arrhythmogenic cardiomyopathy in a large family with a novel in-frame DSP nonsense mutation.

Singh SM, Casey SA, Berg AA, Abdelhadi RH, Katsiyiannis WT, Bennett MK, Mackey-Bojack S, Duncanson ER, Sengupta JD.

Am J Med Genet A. 2018 Jul;176(7):1622-1626. doi: 10.1002/ajmg.a.38719.

PMID:
30160835
3.

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.

Steggerda SM, Bennett MK, Chen J, Emberley E, Huang T, Janes JR, Li W, MacKinnon AL, Makkouk A, Marguier G, Murray PJ, Neou S, Pan A, Parlati F, Rodriguez MLM, Van de Velde LA, Wang T, Works M, Zhang J, Zhang W, Gross MI.

J Immunother Cancer. 2017 Dec 19;5(1):101. doi: 10.1186/s40425-017-0308-4.

4.

Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress.

Wallington-Beddoe CT, Bennett MK, Vandyke K, Davies L, Zebol JR, Moretti PAB, Pitman MR, Hewett DR, Zannettino ACW, Pitson SM.

Oncotarget. 2017 Jul 4;8(27):43602-43616. doi: 10.18632/oncotarget.17115.

5.

Time in Therapeutic Range for Left Ventricular Assist Device Patients Anticoagulated With Warfarin: A Correlation to Clinical Outcomes.

Halder LC, Richardson LB, Garberich RF, Zimbwa P, Bennett MK.

ASAIO J. 2017 Jan/Feb;63(1):37-40. doi: 10.1097/MAT.0000000000000449.

PMID:
27676409
6.

Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure.

Gilotra NA, Bennett MK, Shpigel A, Ahmed HM, Rao S, Dunn JM, Harrington C, Freitag TB, Halushka MK, Russell SD.

Am Heart J. 2016 Sep;179:116-26. doi: 10.1016/j.ahj.2016.06.019. Epub 2016 Jul 5.

PMID:
27595686
7.

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay.

Lee SJ, Levitsky K, Parlati F, Bennett MK, Arastu-Kapur S, Kellerman L, Woo TF, Wong AF, Papadopoulos KP, Niesvizky R, Badros AZ, Vij R, Jagannath S, Siegel D, Wang M, Ahmann GJ, Kirk CJ.

Br J Haematol. 2016 Jun;173(6):884-95. doi: 10.1111/bjh.14014. Epub 2016 Apr 12.

8.

Anticoagulation management in mechanical circulatory support.

Adatya S, Bennett MK.

J Thorac Dis. 2015 Dec;7(12):2129-38. doi: 10.3978/j.issn.2072-1439.2015.10.65. Review.

9.

Blood pressure management in mechanical circulatory support.

Bennett MK, Adatya S.

J Thorac Dis. 2015 Dec;7(12):2125-8. doi: 10.3978/j.issn.2072-1439.2015.11.05. Review.

10.

Lack of Relationship Between Serum Cardiac Troponin I Level and Giant Cell Myocarditis Diagnosis and Outcomes.

Gilotra NA, Minkove N, Bennett MK, Tedford RJ, Steenbergen C, Judge DP, Halushka MK, Russell SD.

J Card Fail. 2016 Jul;22(7):583-5. doi: 10.1016/j.cardfail.2015.12.022. Epub 2016 Jan 6. No abstract available.

PMID:
26768222
11.

Home monitoring of heart failure patients at risk for hospital readmission using a novel under-the-mattress piezoelectric sensor: A preliminary single centre experience.

Bennett MK, Shao M, Gorodeski EZ.

J Telemed Telecare. 2017 Jan;23(1):60-67. doi: 10.1177/1357633X15618810. Epub 2016 Jul 9.

12.

Exploratory investigation of communication management in residential-aged care: a comparison of staff knowledge, documentation and observed resident-staff communication.

Bennett MK, Ward EC, Scarinci NA.

Int J Lang Commun Disord. 2016 May;51(3):296-309. doi: 10.1111/1460-6984.12207. Epub 2015 Nov 17.

PMID:
26575694
13.

Mealtime management in Australian residential aged care: Comparison of documented, reported and observed care.

Bennett MK, Ward EC, Scarinci NA.

Int J Speech Lang Pathol. 2015;17(5):451-9. doi: 10.3109/17549507.2014.987816. Epub 2014 Dec 26.

PMID:
25541741
14.

Perspectives on mealtime management in residential aged care: insights from a cross-disciplinary investigation.

Bennett MK, Ward E, Scarinci N, Waite M.

J Nutr Gerontol Geriatr. 2014;33(4):325-39. doi: 10.1080/21551197.2014.963275.

PMID:
25424509
15.

S100A1 in human heart failure: lack of recovery following left ventricular assist device support.

Bennett MK, Sweet WE, Baicker-McKee S, Looney E, Karohl K, Mountis M, Tang WH, Starling RC, Moravec CS.

Circ Heart Fail. 2014 Jul;7(4):612-8. doi: 10.1161/CIRCHEARTFAILURE.113.000849. Epub 2014 May 19.

16.

A comparison of gateway in-street sign configuration to other driver prompts to increase yielding to pedestrians at crosswalks.

Bennett MK, Manal H, Van Houten R.

J Appl Behav Anal. 2014 Spring;47(1):3-15. doi: 10.1002/jaba.103.

PMID:
24604392
17.

Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Gross MI, Demo SD, Dennison JB, Chen L, Chernov-Rogan T, Goyal B, Janes JR, Laidig GJ, Lewis ER, Li J, Mackinnon AL, Parlati F, Rodriguez ML, Shwonek PJ, Sjogren EB, Stanton TF, Wang T, Yang J, Zhao F, Bennett MK.

Mol Cancer Ther. 2014 Apr;13(4):890-901. doi: 10.1158/1535-7163.MCT-13-0870. Epub 2014 Feb 12.

18.

Reproductive morphology of three species of neotropical harvestmen (Opiliones, Laniatores, Gonyleptoidea).

Bennett MK, Townsend VR Jr.

J Morphol. 2013 Dec;274(12):1415-24. doi: 10.1002/jmor.20191. Epub 2013 Sep 11.

PMID:
24027062
19.

The implications of habitat management on the population viability of the endangered Ohlone tiger beetle (Cicindela ohlone) metapopulation.

Cornelisse TM, Bennett MK, Letourneau DK.

PLoS One. 2013 Aug 12;8(8):e71005. doi: 10.1371/journal.pone.0071005. eCollection 2013.

20.

Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000-2009.

Bennett MK, Gilotra NA, Harrington C, Rao S, Dunn JM, Freitag TB, Halushka MK, Russell SD.

Circ Heart Fail. 2013 Jul;6(4):676-84. doi: 10.1161/CIRCHEARTFAILURE.112.000087. Epub 2013 Jun 3.

PMID:
23733916
21.

Molecular mechanisms of bortezomib resistant adenocarcinoma cells.

Suzuki E, Demo S, Deu E, Keats J, Arastu-Kapur S, Bergsagel PL, Bennett MK, Kirk CJ.

PLoS One. 2011;6(12):e27996. doi: 10.1371/journal.pone.0027996. Epub 2011 Dec 22.

22.

Increased lipofuscin on endomyocardial biopsy predicts greater cardiac improvement in adolescents and young adults.

Parson SJ, Russell SD, Bennett MK, Dunn JM, Gilotra NA, Rao S, Harrington C, Freitag TB, Foster MC, Halushka MK.

Cardiovasc Pathol. 2012 Jul-Aug;21(4):317-23. doi: 10.1016/j.carpath.2011.11.002. Epub 2011 Dec 6.

PMID:
22153555
23.

Pharmacokinetics, pharmacodynamics, metabolism, distribution, and excretion of carfilzomib in rats.

Yang J, Wang Z, Fang Y, Jiang J, Zhao F, Wong H, Bennett MK, Molineaux CJ, Kirk CJ.

Drug Metab Dispos. 2011 Oct;39(10):1873-82. doi: 10.1124/dmd.111.039164. Epub 2011 Jul 13.

PMID:
21752943
24.

Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events.

Arastu-Kapur S, Anderl JL, Kraus M, Parlati F, Shenk KD, Lee SJ, Muchamuel T, Bennett MK, Driessen C, Ball AJ, Kirk CJ.

Clin Cancer Res. 2011 May 1;17(9):2734-43. doi: 10.1158/1078-0432.CCR-10-1950. Epub 2011 Mar 1.

25.

Odor-evoked gene regulation and visualization in olfactory receptor neurons.

Bennett MK, Kulaga HM, Reed RR.

Mol Cell Neurosci. 2010 Apr;43(4):353-62. doi: 10.1016/j.mcn.2010.01.002. Epub 2010 Jan 18.

26.

Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices.

Bennett MK, Roberts CA, Dordunoo D, Shah A, Russell SD.

J Heart Lung Transplant. 2010 May;29(5):593-4. doi: 10.1016/j.healun.2009.11.604. Epub 2010 Jan 8. No abstract available.

PMID:
20060321
27.

Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome.

Parlati F, Lee SJ, Aujay M, Suzuki E, Levitsky K, Lorens JB, Micklem DR, Ruurs P, Sylvain C, Lu Y, Shenk KD, Bennett MK.

Blood. 2009 Oct 15;114(16):3439-47. doi: 10.1182/blood-2009-05-223677. Epub 2009 Aug 11.

28.

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.

Muchamuel T, Basler M, Aujay MA, Suzuki E, Kalim KW, Lauer C, Sylvain C, Ring ER, Shields J, Jiang J, Shwonek P, Parlati F, Demo SD, Bennett MK, Kirk CJ, Groettrup M.

Nat Med. 2009 Jul;15(7):781-7. doi: 10.1038/nm.1978. Epub 2009 Jun 14. Erratum in: Nat Med. 2009 Nov;15(11):1333.

PMID:
19525961
29.

Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).

Zhou HJ, Aujay MA, Bennett MK, Dajee M, Demo SD, Fang Y, Ho MN, Jiang J, Kirk CJ, Laidig GJ, Lewis ER, Lu Y, Muchamuel T, Parlati F, Ring E, Shenk KD, Shields J, Shwonek PJ, Stanton T, Sun CM, Sylvain C, Woo TM, Yang J.

J Med Chem. 2009 May 14;52(9):3028-38. doi: 10.1021/jm801329v.

PMID:
19348473
30.

Development of proteasome inhibitors in oncology and autoimmune diseases.

Bennett MK, Kirk CJ.

Curr Opin Drug Discov Devel. 2008 Sep;11(5):616-25. Review.

PMID:
18729013
31.

Selective binding of sterol regulatory element-binding protein isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver.

Bennett MK, Seo YK, Datta S, Shin DJ, Osborne TF.

J Biol Chem. 2008 Jun 6;283(23):15628-37. doi: 10.1074/jbc.M800391200. Epub 2008 Apr 15.

32.

A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma.

French JJ, Midwinter MJ, Bennett MK, Manas DM, Charnley RM.

HPB (Oxford). 2005;7(4):289-91. doi: 10.1080/13651820510042246.

33.

Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome.

Demo SD, Kirk CJ, Aujay MA, Buchholz TJ, Dajee M, Ho MN, Jiang J, Laidig GJ, Lewis ER, Parlati F, Shenk KD, Smyth MS, Sun CM, Vallone MK, Woo TM, Molineaux CJ, Bennett MK.

Cancer Res. 2007 Jul 1;67(13):6383-91.

34.

Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma.

Kuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ.

Blood. 2007 Nov 1;110(9):3281-90. Epub 2007 Jun 25.

35.

A key role for orphan nuclear receptor liver receptor homologue-1 in activation of fatty acid synthase promoter by liver X receptor.

Matsukuma KE, Wang L, Bennett MK, Osborne TF.

J Biol Chem. 2007 Jul 13;282(28):20164-71. Epub 2007 May 22.

36.

Granular cell tumor as an unusual cause of obstruction at the hepatic hilum: report of a case.

Lochan R, Balupuri S, Bennett MK, Manas DM.

Surg Today. 2006;36(10):934-6.

PMID:
16998691
37.

Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.

Matsukuma KE, Bennett MK, Huang J, Wang L, Gil G, Osborne TF.

J Lipid Res. 2006 Dec;47(12):2754-61. Epub 2006 Sep 6.

38.

A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation.

Zhao H, Li CC, Pardo J, Chu PC, Liao CX, Huang J, Dong JG, Zhou X, Huang Q, Huang B, Bennett MK, Molineaux SM, Lu H, Daniel-Issakani S, Payan DG, Masuda ES.

J Immunol. 2005 May 1;174(9):5288-97.

39.

Selective association of sterol regulatory element-binding protein isoforms with target promoters in vivo.

Bennett MK, Toth JI, Osborne TF.

J Biol Chem. 2004 Sep 3;279(36):37360-7. Epub 2004 Jun 25.

40.

Silence sets on a sensory map.

Bennett MK, Reed RR.

Neuron. 2004 May 27;42(4):521-2. Review.

41.

Cellular localization and antiproliferative effect of peptides discovered from a functional screen of a retrovirally delivered random peptide library.

Hitoshi Y, Gururaja T, Pearsall DM, Lang W, Sharma P, Huang B, Catalano SM, McLaughlin J, Pali E, Peelle B, Vialard J, Janicot M, Wouters W, Luyten W, Bennett MK, Anderson DC, Payan DG, Lorens JB, Bogenberger J, Demo S.

Chem Biol. 2003 Oct;10(10):975-87. No abstract available.

PMID:
14583264
42.

Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia.

Dresner SM, Griffin SM, Wayman J, Bennett MK, Hayes N, Raimes SA.

Br J Surg. 2003 Sep;90(9):1120-8.

PMID:
12945080
43.

Drug discovery in the ubiquitin regulatory pathway.

Wong BR, Parlati F, Qu K, Demo S, Pray T, Huang J, Payan DG, Bennett MK.

Drug Discov Today. 2003 Aug 15;8(16):746-54. Review.

PMID:
12944097
44.

Image analysis can be used to detect spatial changes in the histopathology of pancreatic tumours.

Sims AJ, Bennett MK, Murray A.

Phys Med Biol. 2003 Jul 7;48(13):N183-91.

PMID:
12884936
45.

Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.

Pray TR, Parlati F, Huang J, Wong BR, Payan DG, Bennett MK, Issakani SD, Molineaux S, Demo SD.

Drug Resist Updat. 2002 Dec;5(6):249-58. Review.

PMID:
12531181
46.

Retrovirally delivered random cyclic Peptide libraries yield inhibitors of interleukin-4 signaling in human B cells.

Kinsella TM, Ohashi CT, Harder AG, Yam GC, Li W, Peelle B, Pali ES, Bennett MK, Molineaux SM, Anderson DA, Masuda ES, Payan DG.

J Biol Chem. 2002 Oct 4;277(40):37512-8. Epub 2002 Jul 11.

47.
48.

Comparison of semi-automated image analysis and manual methods for tissue quantification in pancreatic carcinoma.

Sims AJ, Bennett MK, Murray A.

Phys Med Biol. 2002 Apr 21;47(8):1255-66.

PMID:
12030554
49.

The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction.

Wayman J, Bennett MK, Raimes SA, Griffin SM.

Br J Cancer. 2002 Apr 22;86(8):1223-9.

50.

Fractal analysis in the detection of colonic cancer images.

Esgiar AN, Naguib RN, Sharif BS, Bennett MK, Murray A.

IEEE Trans Inf Technol Biomed. 2002 Mar;6(1):54-8.

PMID:
11936597

Supplemental Content

Loading ...
Support Center